NSE:GRANULES (India)  
Granules India Ltd logo

Granules India Ltd

₹ 334.35 (-0.1%) Dec 8
P/E:
17.15
P/B:
3.20
Market Cap:
₹ 82.94B ($ 1.01B)
Enterprise V:
₹ 88.06B ($ 1.07B)
Volume:
615.12K
Avg Vol (2M):
1.41M
Also Trade In:
Volume:
615.12K
Market Cap ₹:
82.94B
Market Cap $:
1.01B
PE Ratio:
17.15
Avg Vol (2-Month):
1.41M
Enterprise Value ₹:
88.06B
Enterprise Value $:
1.07B
PB Ratio:
3.20

Business Description

Description
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.